ZYUS Life Sciences Corporation (ZLSCF)
OTCMKTS · Delayed Price · Currency is USD
0.0501
0.00 (0.00%)
At close: Feb 10, 2026
ZYUS Life Sciences Revenue
ZYUS Life Sciences had revenue of 105.00K CAD in the quarter ending September 30, 2025, a decrease of -14.63%. This brings the company's revenue in the last twelve months to 465.00K, up 2.88% year-over-year. In the year 2024, ZYUS Life Sciences had annual revenue of 481.00K with 37.04% growth.
Revenue (ttm)
465.00K CAD
Revenue Growth
+2.88%
P/S Ratio
114.37
Revenue / Employee
n/a
Employees
n/a
Market Cap
38.18M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 481.00K | 130.00K | 37.04% |
| Dec 31, 2023 | 351.00K | 53.00K | 17.79% |
| Dec 31, 2022 | 298.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 247.00 | -155.00 | -38.56% |
| Dec 31, 2019 | 402.00 | -749.00 | -65.07% |
| Dec 31, 2018 | 1.15K | -459.00 | -28.51% |
| Dec 31, 2017 | 1.61K | -5.82K | -78.34% |
| Dec 31, 2016 | 7.43K | 1.42K | 23.55% |
| Dec 31, 2015 | 6.02K | -32.96K | -84.56% |
| Dec 31, 2014 | 38.97K | -9.67K | -19.87% |
| Dec 31, 2013 | 48.64K | 47.17K | 3,204.14% |
| Dec 31, 2012 | 1.47K | -1.37K | -48.19% |
| Dec 31, 2011 | 2.84K | 2.52K | 779.57% |
| Dec 31, 2010 | 323.00 | -10.34K | -96.97% |
| Dec 31, 2009 | 10.66K | -22.24K | -67.59% |
| Dec 31, 2008 | 32.90K | -7.40K | -18.36% |
| Dec 31, 2007 | 40.30K | -26.18K | -39.39% |
| Dec 31, 2006 | 66.48K | -106.59K | -61.59% |
| Dec 31, 2005 | 173.07K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 423.75M |
| The Cannabist Company Holdings | 349.84M |
| Jushi Holdings | 260.43M |
| MariMed | 157.38M |
| Earth Science Tech | 33.84M |
| Radnostix | 14.07M |
| Healthy Extracts | 3.59M |
| Growth Stalk Holdings | 583.34K |
ZYUS Life Sciences News
- 4 weeks ago - ZYUS Life Sciences Announces LIFE Offering of a minimum of C$15 Million and maximum of C$16 Million of Units - GlobeNewsWire
- 5 weeks ago - ZYUS Life Sciences Reports Preliminary Results from Ongoing Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug - PRNewsWire
- 6 months ago - ZYUS Life Sciences Activates First Clinical Site and Enrolls First Patient in Phase 2a UTOPIA-1 Cancer Pain Trial - PRNewsWire
- 7 months ago - ZYUS Life Sciences Strengthens Clinical Leadership with Appointment of Chief Medical Officer to Support Phase 2 Oncology Pain Trial - Business Wire
- 8 months ago - Brent H. Zettl Provides Update on Holdings of ZYUS Life Sciences Corporation - Business Wire
- 8 months ago - ZYUS Life Sciences Announces Closing of Unit Offering - Business Wire
- 8 months ago - ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering - Business Wire
- 9 months ago - ZYUS Life Sciences Finalizing Site Initiation for Phase 2A Clinical Trial Advancing Novel Non-Opioid Pain Drug - Business Wire